Target Price | $325.67 |
Price | $310.67 |
Potential |
4.83%
register free of charge
|
Number of Estimates | 21 |
21 Analysts have issued a price target Insulet Corporation 2026 .
The average Insulet Corporation target price is $325.67.
This is
4.83%
register free of charge
$360.00
15.88%
register free of charge
$266.00
14.38%
register free of charge
|
|
A rating was issued by 27 analysts: 20 Analysts recommend Insulet Corporation to buy, 7 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Insulet Corporation stock has an average upside potential 2026 of
4.83%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 2.07 | 2.52 |
22.07% | 21.46% | |
EBITDA Margin | 18.81% | 22.39% |
9.03% | 19.02% | |
Net Margin | 19.63% | 11.21% |
61.06% | 42.90% |
21 Analysts have issued a sales forecast Insulet Corporation 2025 . The average Insulet Corporation sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Insulet Corporation EBITDA forecast 2025. The average Insulet Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 Insulet Corporation Analysts have issued a net profit forecast 2025. The average Insulet Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 5.78 | 4.01 |
96.60% | 30.62% | |
P/E | 77.53 | |
EV/Sales | 8.85 |
16 Analysts have issued a Insulet Corporation forecast for earnings per share. The average Insulet Corporation EPS is
This results in the following potential growth metrics and future valuations:
Insulet Corporation...
Analyst | Rating | Action | Date |
---|---|---|---|
Oppenheimer |
Locked
➜
Locked
|
Locked | May 09 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
Wolfe Research |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Mar 06 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
Raymond James |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
Analyst Rating | Date |
---|---|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 09 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Apr 30 2025 |
Locked
Wolfe Research:
Locked
➜
Locked
|
Apr 29 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Mar 06 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 21 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Feb 21 2025 |
Locked
Raymond James:
Locked
➜
Locked
|
Feb 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.